CN110776460B - Fluorescent compound for LED visible light induced release of nitric oxide and preparation and application thereof - Google Patents
Fluorescent compound for LED visible light induced release of nitric oxide and preparation and application thereof Download PDFInfo
- Publication number
- CN110776460B CN110776460B CN201910641530.7A CN201910641530A CN110776460B CN 110776460 B CN110776460 B CN 110776460B CN 201910641530 A CN201910641530 A CN 201910641530A CN 110776460 B CN110776460 B CN 110776460B
- Authority
- CN
- China
- Prior art keywords
- compound
- nitric oxide
- formula
- fluorescent
- light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title claims abstract description 93
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 69
- 238000000034 method Methods 0.000 claims abstract description 11
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 5
- 230000035755 proliferation Effects 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 34
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 22
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 238000012544 monitoring process Methods 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 238000002390 rotary evaporation Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000003480 eluent Substances 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 abstract description 9
- 201000011510 cancer Diseases 0.000 abstract description 8
- 230000006698 induction Effects 0.000 abstract description 7
- 230000004044 response Effects 0.000 abstract description 7
- 206010034972 Photosensitivity reaction Diseases 0.000 abstract description 5
- XJHABGPPCLHLLV-UHFFFAOYSA-N benzo[de]isoquinoline-1,3-dione Chemical compound C1=CC(C(=O)NC2=O)=C3C2=CC=CC3=C1 XJHABGPPCLHLLV-UHFFFAOYSA-N 0.000 abstract description 5
- 208000007578 phototoxic dermatitis Diseases 0.000 abstract description 5
- 231100000018 phototoxicity Toxicity 0.000 abstract description 5
- 238000012984 biological imaging Methods 0.000 abstract description 2
- 230000006378 damage Effects 0.000 abstract description 2
- 239000000975 dye Substances 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 29
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 22
- 238000005286 illumination Methods 0.000 description 16
- 239000008055 phosphate buffer solution Substances 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 9
- 238000012258 culturing Methods 0.000 description 7
- 230000005284 excitation Effects 0.000 description 7
- 238000001819 mass spectrum Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000799 fluorescence microscopy Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 238000002189 fluorescence spectrum Methods 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Substances [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- HDFQKJQEWGVKCQ-UHFFFAOYSA-N 1,3-dimethyl-2-nitrobenzene Chemical group CC1=CC=CC(C)=C1[N+]([O-])=O HDFQKJQEWGVKCQ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- FVHAWXWFPBPFOS-UHFFFAOYSA-N 1,2-dimethyl-3-nitrobenzene Chemical compound CC1=CC=CC([N+]([O-])=O)=C1C FVHAWXWFPBPFOS-UHFFFAOYSA-N 0.000 description 1
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- NDZJSUCUYPZXPR-UHFFFAOYSA-N 1-nitro-2-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC=CC=C1C(F)(F)F NDZJSUCUYPZXPR-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- TZASZCQVZPLXHP-UHFFFAOYSA-N 2,6-dimethyl-3-nitrophenol Chemical group CC1=CC=C([N+]([O-])=O)C(C)=C1O TZASZCQVZPLXHP-UHFFFAOYSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000008463 key metabolic pathway Effects 0.000 description 1
- 238000002514 liquid chromatography mass spectrum Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 1
- 231100000783 metal toxicity Toxicity 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002840 nitric oxide donor Substances 0.000 description 1
- 150000005181 nitrobenzenes Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000006884 regulation of angiogenesis Effects 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 238000005316 response function Methods 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The invention relates to a LED, a fluorescent compound (I) capable of releasing nitric oxide under the induction of visible light, and a preparation method and application thereof. The compound (I) can sufficiently release nitric oxide under the induction of LED yellow light, and reaches the concentration of the nitric oxide released by similar compounds under the induction of ultraviolet; meanwhile, the fluorescence response induced by LED yellow light (18W) in the PBS solution is higher than that induced by common ultraviolet light (8W), so that the method is better applied to cell biological imaging; according to the invention, the LED yellow light source is used as a trigger light source for nitric oxide release, and the two-photon dye is used as a compound fluorescent parent, so that the phototoxicity is greatly reduced during application, and the damage to organisms and cells is reduced; due to the good light stability and thermal stability of the conjugated structure containing the naphthalimide, the compound (I) can be irradiated in organisms for a long time and can continuously release nitric oxide for a long time, and can be applied to inhibiting the proliferation of cancer cells.
Description
(I) technical field
The invention relates to a fluorescent compound capable of releasing nitric oxide under the induction of LED visible light, and a preparation method and application thereof.
(II) background of the invention
Nitric Oxide (NO) is considered to be an important gaseous signaling molecule that plays an important role in a variety of physiological and pathological processes, and is involved in the regulation of angiogenesis, blood flow and vascular function. In recent years, NO has not only found its important role in various biological functions, but also has potential anticancer activity, and the level of NO in tumors and its microenvironment can directly affect the response of cancer cells to excessive amounts of NO (more than several hundred nanomolar) can destroy DNA or mitochondria through apoptosis mechanisms, inhibit key metabolic pathways, block growth or completely kill cancer cells. NO may also exert a local cytotoxic effect on infectious microorganisms; can also be used as free radical scavenger to reduce free radical mediated oxidation process. Therefore, the carbon monoxide release molecule which constructs rapid and accurate space-time control and has the fluorescence response function and cancer cytotoxicity has important application value.
Several classes of nitric oxide releasing molecules with different release mechanisms and kinetics have been developed so far, but real-time monitoring and control of the released concentration are difficult, and heavy metal toxicity is present in part. Compared with the prior art, the light-induced on/off triggered nitric oxide releasing molecules have the advantages of being relatively mild, and the existing light-induced released fluorescent molecules are induced by an ultraviolet light source, a pulse light source and a halogen lamp light source and have the defects of high phototoxicity, high cost and inconvenience in use.
Disclosure of the invention
The invention aims to provide a fluorescent compound for inducing the release of nitric oxide by LED visible light, and a preparation method and application thereof.
The technical scheme adopted by the invention is as follows:
an LED visible light-induced nitric oxide-releasing fluorescent compound has a structure shown in formula (I):
compared with a compound with a similar effect, the compound (I) provided by the invention firstly uses the fluorescent molecules released by the nitric oxide induced by the LED yellow light source, has obvious fluorescent response, small phototoxicity and high light stability, has the performance of releasing the nitric oxide by long-time illumination, can be applied to inhibiting cell proliferation, and simultaneously meets the requirements of monitoring the nitric oxide release and biological cell imaging.
The invention also relates to a method for preparing the fluorescent compound, which comprises the following steps: under the conditions of ice bath at 0 ℃ and nitrogen protection, adding a compound shown as a formula (II) dissolved in anhydrous tetrahydrofuran into an anhydrous tetrahydrofuran solution added with NaH, continuously reacting for 1-2 hours at a low temperature, adding a compound shown as a formula (III) dissolved in anhydrous tetrahydrofuran, continuously reacting for 5-6 hours at room temperature, and separating and purifying to obtain a compound shown as a formula (I) after the reaction is finished;
preferably, the amount ratio of the compound (II), the compound (III) and the NaH substance is 1:0.7: 3. The volume of the anhydrous tetrahydrofuran is 20mL/mmol based on the amount of the compound substance shown in the formula (II).
Specifically, the separation and purification method comprises the following steps: removing the solvent from the reaction solution by rotary evaporation under reduced pressure, and separating the concentrate by a silica gel column, wherein the reaction solution is prepared by the following steps of: and (3) taking a mixed solution with the methanol volume ratio of 20:1 as an eluent, collecting a target component, and drying to obtain the fluorescent compound shown in the formula (I) (a nuclear magnetic hydrogen spectrum is shown in figure 1a, and a mass spectrum is shown in figure 1 b).
The formula (II) of the invention is a disclosed compound, and the preparation method thereof can be referred to as the literature: [ T, Suzuki, O.Nagae, Y.Kato, H.Nakagawa, K.Fukuhara, and N.Miyata, Photoinked Nitric Oxide Release from Nitrobenzene Derivatives, J.Am. chem.Soc., 127(2005)1720 11726 ]
The formula (III) of the invention is a disclosed compound, and the preparation method thereof can be referred to as the literature: [ H, Park, S. -K.Chang, signalling of water content in organic solvents by solvatochromism of ahydroxynapthalimide-based merocyanine dye, DyesPigm,122(2015)324-
The invention also relates to application of the fluorescent compound in preparing a fluorescent probe.
In particular, the fluorescent probe is used for photoinduced monitoring of nitric oxide release.
The synthesis route of the nitric oxide releasing fluorescent compound of formula (I) is as follows:
the invention simultaneously prepares other two new nitric oxide releasing fluorescent molecules:
detection experiments prove that the o-trifluoromethyl nitrobenzene light release groups in the compound (A) (the mass spectrogram is shown in figure 3a) and the compound (B) (the mass spectrogram is shown in figure 3B) cannot effectively release nitric oxide under an LED visible light source. The cy-7 parent of the compound (A) is easy to crack under the illumination condition due to a huge conjugated structure, and has no application capability; the parent of the naphthalimide of the compound (B) meets the requirement of long-time illumination, can effectively release nitric oxide under the condition of ultraviolet illumination, but has insignificant effects of fluorescence quenching and photoinduced turn-on based on photoinduced electron transfer. In contrast, the fluorescent compound (I) takes the naphthalimide with good light stability as a parent body, and is connected with the o-dimethyl nitrobenzene in a conjugated manner, so that the fluorescent turn-on performance after the nitric oxide is released by good fluorescent quenching and light induction is generated.
In the present invention, the 2, 6-dimethylnitrobenzene structure of compound (I) acts as a nitric oxide donor, and the nitro group is unstably perpendicular to the plane of the benzene ring due to the large steric hindrance caused by the methyl group ortho to the nitro group. Under the irradiation condition of an 18W yellow LED lamp source, the naphthalimide fluorescent parent absorbs irradiation light energy and transmits the irradiation light energy to a donor, NO molecules are easily released, and the 2, 6-dimethyl nitrobenzene structure is converted into a 2, 6-dimethyl nitrophenol structure (a high performance liquid chromatogram is shown in figure 2a, and a mass spectrogram is shown in figure 2 b). At this time, the fluorescent compound (I) fluoresces turn-on due to an intramolecular charge transfer effect.
The fluorescence detection method of the nitric oxide releasing fluorescent compound I comprises the following steps: the solution of compound (I) was illuminated under 18W yellow LED lamp with a lamp spacing of 20 cm. After light irradiation, fluorescence response is detected by using a microplate reader, the fluorescence excitation wavelength is set to 410nm, the maximum fluorescence emission wavelength is 520nm, and the illumination time fluorescence spectrum and the concentration gradient fluorescence spectrum of the compound I are obtained.
In particular, the fluorescent probe can be used for fluorescent confocal cell imaging. The specific method can be as follows: the compound (I) is used as a fluorescent probe, and is incubated with HeLa cells in a culture solution for 30 minutes, and fluorescence imaging is carried out under a confocal microscope after the illumination of an LED visible light source.
The invention also relates to application of the fluorescent compound in preparing a medicament for inhibiting cancer cell proliferation. The compound (I) and cancer cells are incubated for 1 hour, the lamp source is irradiated for a certain time and then is continuously cultured for 12 hours, and the survival rate of the cells is measured by an MTT method, so that the compound (I) has obvious inhibition effect on the cancer cells.
Preferably, the cancer cell is a Hela cell.
The invention has the following beneficial effects: the compound (I) can sufficiently release nitric oxide under the induction of LED yellow light, and reaches the concentration of the nitric oxide released by similar compounds under the induction of ultraviolet; meanwhile, in the PBS solution, the fluorescence response induced by the yellow light of the LED is higher than that induced by common ultraviolet (365nm/8W), so that the fluorescent response is better applied to cell biological imaging; according to the invention, an LED yellow light source (18W) is used as a trigger light source for releasing nitric oxide, and a two-photon dye is used as a compound fluorescent parent, so that the phototoxicity is greatly reduced during application, and the damage to organisms and cells is reduced; due to the good light stability and thermal stability of the conjugated structure containing the naphthalimide, the compound (I) can be irradiated in organisms for a long time and can continuously release nitric oxide for a long time, and can be applied to inhibiting the proliferation of cancer cells.
(IV) description of the drawings
FIG. 1a is a nuclear magnetic hydrogen spectrum of compound (I) in the present invention.
FIG. 1b is a mass spectrum of compound (I) according to the present invention.
FIG. 2a is a high performance liquid chromatogram of a solution of compound (I) in the present invention after light irradiation.
FIG. 2b is a mass spectrum of the photoproduct of compound (I) according to the present invention.
FIG. 3a is a mass spectrum of Compound (A) in the present invention.
FIG. 3B is a mass spectrum of the compound (B) of the present invention.
FIG. 4 is a graph showing the change of fluorescence intensity with time of illumination of compound (I) of the present invention in a 1% dimethylsulfoxide PBS solution at a concentration of 50. mu.M, with an 18W yellow LED lamp, the excitation wavelength being 410nm and the emission wavelength being 520 nm.
FIG. 5 shows the fluorescence intensity as a function of the concentration of compound (I) of the present invention in 1% dimethylsulfoxide in PBS for 30 minutes under irradiation with a lamp source, the excitation wavelength being 410nm and the emission wavelength being 520 nm.
FIG. 6 shows the change of fluorescence intensity of compound (I) in 1% dimethylsulfoxide in PBS at a concentration of 100. mu.M after 2 hours of irradiation with different light sources, with an excitation wavelength of 410nm and an emission wavelength of 520 nm.
FIG. 7a is the concentration of nitric oxide released from compound (I) in 1% DMSO-PBS at 50 μ M for different periods of time under illumination with a 18W yellow LED light source; FIG. 7b is a standard curve.
FIG. 8a is the concentration of nitric oxide released from the probe (I) in 1% dimethylsulfoxide (PBS) solution within 1 hour of illumination by the lamp at concentrations of compound (I) of 2. mu.M, 5. mu.M, 10. mu.M, 50. mu.M, and 100. mu.M; fig. 8b is a standard curve.
FIG. 9 shows the cell viability after the HeLa cells in the culture medium were irradiated with 18W yellow LED light for 10 minutes, 30 minutes, and 60 minutes and further cultured for 12 hours.
FIG. 10 shows the cell viability of compound (I) at concentrations of 2. mu.M, 5. mu.M, 10. mu.M, 50. mu.M and 100. mu.M after culturing in Hela cell culture medium for 30 minutes without exposure to light, respectively, and further for 12 hours.
FIG. 11 is a confocal fluorescent image of compound (I) in HeLa cells irradiated with light from the lamp for different periods of time. 1) 2), 3) the light irradiation time was 0 minute, 4), 5), 6) the light irradiation time was 30 minutes, 7), 8), 9) the light irradiation time was 60 minutes.
(V) detailed description of the preferred embodiments
The invention will be further described with reference to specific examples, but the scope of the invention is not limited thereto:
example 1: synthesis of Compound (I)
In a 50mL round-bottom flask, 100mg of Compound 6 (0.33mmol) was dissolved in 1mL of anhydrous tetrahydrofuran at 0 ℃ under nitrogen protection, and 40mg of NaH (60% content, 1.00mmol of NaH) dissolved in 3mL of anhydrous tetrahydrofuran was added and stirred for 1.5 hours. 70mg of Compound 8(0.23mmol) was dissolved in 3mL of anhydrous tetrahydrofuran and added to the reaction mixture, and the reaction was carried out at ordinary temperature for 6 hours. The TLC plate reaction was completed, the solvent was removed by rotary evaporation of the mixture under reduced pressure, and the concentrate was subjected to silica gel column separation (dichloromethane: methanol 20:1, v/v) to obtain 63.5mg of a red solid in 62% yield. The nuclear magnetic hydrogen spectrum is shown in figure 1a, and the mass spectrum is shown in figure 1 b.
1H NMR(600MHz,DMSO)δ8.67(d,J=7.7Hz,2H),8.42(s, 1H),7.81–7.75(m,1H),7.58(s,2H),7.37(d,J=16.4Hz,1H),4.03 (d,J=6.0Hz,2H),2.30(s,6H),1.61(s,2H),1.35(dd,J=14.7,7.4 Hz,2H),1.23(t,J=7.0Hz,2H),0.93(t,J=7.4Hz,3H). C26H24N2O5[M-H]444.17,found 443.48.
Example 2:
compound (I) 4.45mg of Compound (I) was accurately weighed, 10mM probe stock solution was prepared using dimethyl sulfoxide, 5. mu.L of the solution was pipetted into 995. mu. LPBS solution (pH7.2, 50mmol/L) at a concentration of 50. mu.M, and the fluorescence was measured at 37 ℃ for 3 minutes, 10 minutes, 30 minutes, 1 hour, 1.5 hours, and 2 hours using 18w yellow LED light, at an excitation wavelength of 410nm and an emission wavelength of 520nm, as shown in FIG. 4. The HPLC diagram of the light product is shown in FIG. 2a, and the mass spectrum diagram is shown in FIG. 2 b. C26H25NO4[M-H]414.18, found 414.35.
Experiments prove that in PBS solution, under the condition that the emission wavelength is 520nm, the fluorescence intensity of the compound (I) due to illumination turn-on increases along with the increase of illumination time, and the fluorescence is enhanced by 60 times after 2 hours. The LC-MS spectrum simultaneously proves the generation of the photoproduct compound II in the solution and the correctness of the mechanism.
Example 3:
the pipette was pipetted 10. mu.L of the compound (I) stock solution (10mM) into 990. mu.L of PBS solution (pH7.2, 50mmol/L) at a compound (I) concentration of 100. mu.M, diluted sequentially to different concentrations (0. mu.M, 1. mu.M, 5. mu.M, 10. mu.M, 20. mu.M, 50. mu.M), irradiated with 18w yellow LED light for 30 minutes, and the fluorescence was measured at 37 ℃ under excitation at 410 nm. The emission wavelength was 520nm and the fluorescence spectrum is shown in FIG. 5.
Experiments prove that in a PBS (phosphate buffer solution), under the condition that the emission wavelength is 520nm, the fluorescence intensity of the fluorescent compound (I) is gradually enhanced along with the increase of the concentration of the compound (I) after the fluorescent compound (I) is irradiated for 30 minutes, and a certain linear relation is shown.
Example 4:
the pipette gun pipetted 10. mu.L of the compound (I) stock solution (10mM) to 990. mu.L of LPBS solution (pH7.2, 50mmol/L) at a probe concentration of 100. mu.M. Respectively irradiating under 18W yellow LED light source, ultraviolet 365nm light source (8W) and natural light for 2 hr, and measuring fluorescence value at 37 deg.C with excitation wavelength of 410nm and emission wavelength of 520nm under dark condition as control, wherein the fluorescence spectrogram is shown in FIG. 6.
Experiments prove that in the PBS solution, the compound (I) has good fluorescent response to the irradiation of an 18W LED yellow lamp source, and is superior to a common ultraviolet lamp source.
Example 5:
formulation of 0 to 100. mu.M gradient NaNO2After adding Griess reagent, the absorbance at 540nm was measured to obtain the NO concentration standard curve (FIG. 7 b). The pipette gun pipetted 5. mu.L of the compound (I) stock solution (10mM) to 995. mu.L of PBS solution (pH7.2, 50mmol/L) at a compound (I) concentration of 50. mu.M. Set 4 sets of replicates and irradiate with 18W yellow LED lamp for 10 min, 20 min, 30min, 40 min, and 50 μ L of each sample was added to a 96 well plate. 50 μ L of Griess I and II solutions were added to each well, incubated for 10 minutes, and then the absorbance at 540nm was measured with a microplate reader to obtain the NO release concentration according to a standard curve (see FIG. 7 a).
Experiments prove that the compound (I) can effectively release nitric oxide under 18W yellow LED light, the release concentration is increased along with the illumination time, and the release duration is more than 1 hour.
Example 6:
a gradient NaNO2 solution of 0 to 100. mu.M was prepared, and the absorbance at 540nm was measured after adding Griess reagent to obtain a standard NO concentration curve (FIG. 8 b). The pipette gun pipetted 10. mu.L of the compound (I) stock solution (10mM) into 990. mu.L of PBS solution (pH7.2, 50 mmol/L). The dilution was sequentially carried out at different concentrations (0. mu.M, 1. mu.M, 5. mu.M, 10. mu.M, 20. mu.M, 50. mu.M), and 4 sets of replicates were set. After 1 hour of illumination with 18W yellow LED light, 50. mu.L of each sample was added to a clear 96-well plate. 50 μ L of Griess I and II solutions were added to each well, incubated for 10 minutes, and then the absorbance at 540nm was measured with a microplate reader, and the NO release concentration was obtained according to a standard curve (see FIG. 8 a).
Experiments prove that the probes (I) with different concentrations can effectively release nitric oxide under 18W yellow LED light, the release concentration is increased along with the concentration of the probes, and the release concentration of 100 mu M of the compound (I) nitric oxide can reach 10 mu M.
Example 7:
hela cells were cultured in a transparent 96-well plate at a constant temperature of 37 ℃ under 5% CO2, the plate was covered with the Hela cells, and then irradiated under an 18W yellow LED light source for 10 minutes, 30 minutes, and 60 minutes, and all the cells were set in 5 groups in parallel with each other as a control. And continuing to culture at constant temperature for 12 hours, sucking out the culture solution, adding fresh culture solution, adding 10 mu L (5mg/mL) of MTT PBS solution, continuing to culture for 4 hours, stopping culturing, sucking out the culture solution, adding 150 mu L of DMSO into each hole, detecting an absorption value at 490nm by using a microplate reader, setting the OD value of light-shielding culture to be 1, and calculating the survival rate of the cells. (see FIG. 9).
Experiments prove that the LED visible light source used in the invention has low phototoxicity, and the influence of irradiation for 60 minutes on the normal proliferation of cell growth does not exceed 10% of the total number of normal cultured cells.
Example 8:
hela cells were plated in clear 96-well plates at 37 ℃ with 5% CO2The culture was carried out at a constant temperature, and after the well plate was covered, 1. mu.L of compound I at different concentrations was added to the culture solution to give final concentrations of 0. mu.M, 10. mu.M, 30. mu.M, and 50. mu.M. Culturing at 37 deg.C under 5% CO2 at constant temperature, incubating for 1 hr, irradiating under 18W yellow LED lamp for 30min, and setting 5 groups at all concentrations as control. Culturing is continued for 12 hours, the culture solution is aspirated and fresh culture solution is added, 10 mu L (5mg/mL) of MTT PBS solution is added, the culturing is stopped after continuing to culture for 4 hours, 150 mu L of DMSO is added to each well after the culture solution is aspirated, the absorbance at 490nm is detected by a microplate reader, the OD value of the light-shielded culture without the compound (I) is 1, and the cell survival rate is calculated. (see FIG. 10).
Experiments prove that after illumination, the compound (I) releases nitric oxide with a concentration exceeding the inhibition concentration, and the average inhibition rate reaches 49.1% when the compound (I) is at a concentration of 50 mu M in the co-culture with cells.
Example 9:
HeLa cells were found to be approximately 3 x 105The cells were inoculated and cultured in 3 confocal plates respectively, and cultured in DMEM at 37 deg.C and 5% CO2The incubation was performed at constant temperature under the conditions, after 24 hours of incubation, DMEM medium was removed, PBS 7.2 buffer was washed 3 times, and 1. mu.L of compound (I) in DMSO was added to 999. mu.L of fresh DMEM medium to a final concentration of 25. mu.M. After mixing uniformly, the mixture was added to the cells in a confocal dish and incubated at 37 ℃ for 15 minutes. The light was irradiated with a yellow LED light source for 0min, 30min and 60 min, respectively. And continuing to culture for 2 hours at constant temperature, removing DMEM culture solution, washing 3 times by PBS 7.2 buffer solution, and performing fluorescence imaging by using a fluorescence confocal microscope, wherein the emission wavelength is 520 nm. (see FIG. 11). 1) And 2) and 3) culturing in a dark place; 4) 5) and 6) culturing after illumination for 30 minutes; 7) 8), 9) was incubated under light for 60 minutes. Wherein 1), 4) and 7) are bright field images; 2) 5), 8) fluorescence imaging; 3) 6), 9) are superimposed images.
Experiments prove that as the illumination time increases, the fluorescent signal in the cells is gradually enhanced, and compared with the cells cultured in the dark, the morphology of part of the cells is changed. The compound (I) has the function of intracellular fluorescence imaging, and the released nitric oxide has destructive effect on the growth of cancer cells.
Claims (6)
2. a method of making the fluorescent compound of claim 1, the method comprising: under the conditions of ice bath at 0 ℃ and nitrogen protection, adding a compound shown as a formula (II) dissolved in anhydrous tetrahydrofuran into an anhydrous tetrahydrofuran solution added with NaH, continuously reacting for 1-2 hours, adding a compound shown as a formula (III) dissolved in anhydrous tetrahydrofuran, continuously reacting for 5-6 hours at room temperature, and separating and purifying after the reaction is finished to obtain a compound shown as a formula (I);
3. the method according to claim 2, wherein the amount of the compound of formula (II), the amount of the compound of formula (III) and the amount of NaH is 1:0.7:3, and the volume of the anhydrous tetrahydrofuran is 20mL/mmol based on the amount of the compound of formula (II).
4. The method according to claim 2, wherein the separation and purification method comprises: removing the solvent from the reaction solution by rotary evaporation under reduced pressure, and separating the concentrate by a silica gel column, wherein the reaction solution is prepared by the following steps of: and (3) taking a mixed solution with the methanol volume ratio of 20:1 as an eluent, collecting a target component, and drying to obtain the fluorescent compound shown in the formula (I).
5. Use of the fluorescent compound of claim 1 in the preparation of a fluorescent probe for LED light-induced monitoring of nitric oxide release.
6. Use of the fluorescent compound of claim 1 in the manufacture of a medicament for inhibiting proliferation of Hela cells.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910641530.7A CN110776460B (en) | 2019-07-16 | 2019-07-16 | Fluorescent compound for LED visible light induced release of nitric oxide and preparation and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910641530.7A CN110776460B (en) | 2019-07-16 | 2019-07-16 | Fluorescent compound for LED visible light induced release of nitric oxide and preparation and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110776460A CN110776460A (en) | 2020-02-11 |
CN110776460B true CN110776460B (en) | 2021-05-04 |
Family
ID=69383879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910641530.7A Active CN110776460B (en) | 2019-07-16 | 2019-07-16 | Fluorescent compound for LED visible light induced release of nitric oxide and preparation and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110776460B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106929006B (en) * | 2017-01-22 | 2019-05-31 | 浙江工业大学 | It is a kind of using naphthalimide as the identification cysteine of parent nucleus and homocysteine fluorescence probe and its preparation and application |
CN109593078B (en) * | 2018-12-29 | 2021-01-01 | 太原师范学院 | N-butyl-4-hydroxy-1, 8-naphthalimide-3-formaldehyde- (2-pyridine) hydrazone and application thereof |
-
2019
- 2019-07-16 CN CN201910641530.7A patent/CN110776460B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN110776460A (en) | 2020-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10935498B1 (en) | Fluorescent probe for detecting nitroreductase and preparation method and use thereof in enzymatic reaction | |
Liu et al. | A red emitting fluorescent probe for instantaneous sensing of thiophenol in both aqueous medium and living cells with a large Stokes shift | |
Sun et al. | Iridium (III) anthraquinone complexes as two‐photon phosphorescence probes for mitochondria imaging and tracking under hypoxia | |
CN108373447B (en) | Fluorescent probe for distinguishing dead/living cells and synthetic method and application thereof | |
CN105732564A (en) | Two-photon fluorescence probe and application thereof in detecting anoxic-zone nitroreductase | |
CN112961177B (en) | Near-infrared fluorescent probe for detecting reduced nicotinamide adenine dinucleotide NADH and preparation method and application thereof | |
CN113087703B (en) | Photosensitizer capable of specifically marking lipid droplets and preparation method thereof | |
CN109796483A (en) | A kind of water-soluble cationic photosensitizer and its preparation and application | |
CN110642882B (en) | Fluorescent probe with hydrogen peroxide detection and photodynamic cancer cell killing activity as well as preparation method and application thereof | |
CN108484479B (en) | Carbazolyl two-photon fluorescent probe and preparation method and application thereof | |
Tian et al. | Ratiometric fluorescence imaging for sodium selenite in living cells | |
US20220275274A1 (en) | Neutral fluorescent mitochondrial marker based on nitrogen-containing heterocycle, preparation method and use thereof | |
CN110776460B (en) | Fluorescent compound for LED visible light induced release of nitric oxide and preparation and application thereof | |
CN109456352A (en) | The hydrogen peroxide of borate ester modification can two pyrroles's photosensitizer of activation type fluorine boron and its preparation | |
CN108774249B (en) | Oxazine compound and application thereof | |
CN108358972B (en) | Phenanthroline ruthenium complex photosensitive dye and preparation method and application thereof | |
CN112939863A (en) | High-brightness and high-light stability lipid drop fluorescent probe and synthetic method and application thereof | |
US20230159819A1 (en) | Neutral fluorescent mitochondrial marker as amide derivative, and preparation method and use thereof | |
CN115521293A (en) | Hydrazide luminescent dye and its preparation method and application | |
CN113416196A (en) | benzothiadiazole-TB compound and synthesis method and application thereof | |
CN115572304A (en) | Reaction system and method for releasing aldehyde compound by visible light induced BODIPY photocage molecule | |
Vargas et al. | Studies of the photooxidant properties of antibacterial fluoroquinolones and their naphthalene derivatives | |
CN115353460B (en) | Application of phenol-containing keto-salicylaldehyde hydrazine compound in endoplasmic reticulum imaging | |
CN113717544B (en) | Rapid and long-time lysosome or cell nucleus targeted near-infrared staining reagent based on aminofluorene skeleton, and preparation method and application thereof | |
CN113583033B (en) | benzothiadiazole-TB-fluoroboron complex and synthesis method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |